Suchergebnisse - "Dexamethasone"

PubPharm (140.415)

61

Activation of glucocorticoid receptor signaling inhibits KSHV-induced inflammation and tumorigenesis

enthalten in: bioRxiv.org | 2024

von Chen, L. | Ding, L. | Wang, X. | +2

62

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

enthalten in: bioRxiv.org | 2024

von Nadeem, O. | Aranha, M. | Redd, R. | +19

63

A Study to Determine Dose, Safety, Tolerability, Drug Levels, and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Participants With Multiple Myeloma : A Phase 1b/2a Multicenter, Open-label, Dose-escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination With Other Treatments in Subjects With Multiple Myeloma

enthalten in: ClinicalTrials.gov | 2024

64

Dexamethasone in Controlling Dyspnea in Patients With Cancer : A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer Patients

enthalten in: ClinicalTrials.gov | 2024

65

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy : A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy

enthalten in: ClinicalTrials.gov | 2024

66

Steroids After Spine Fusion Surgery : Postoperative Steroids and Recovery After Spine Fusion

enthalten in: ClinicalTrials.gov | 2024

67

Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients : Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients (SABLe): An Investigator Sponsored Trial

enthalten in: ClinicalTrials.gov | 2024

68

A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) : A Phase III Randomized, Controlled, Multicenter, Open-label Study of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

enthalten in: ClinicalTrials.gov | 2024

69

Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone : Nutrition Intervention for Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone

enthalten in: ClinicalTrials.gov | 2024

70

A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma : A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma

enthalten in: ClinicalTrials.gov | 2024